13849-05-3

Upstream product

• 52085-14-0 4-benzoxy-salicylaldehyde 
• 182747-75-7 methyl 6-hydroxybenzofuran-2-carboxylate 
• 100-39-0 benzyl bromide 
• 55364-67-5 6-methoxy-2-benzofurancarboxylic acid methyl ester 
• 673-22-3 2-Hydroxy-4-methoxybenzaldehyde 
• 95-01-2 2,4-Dihydroxybenzaldehyde 
• 100-44-7 benzyl chloride 
• 412300-56-2 (5-benzyloxy-2-formyl-phenoxy)-acetic acid methyl ester 
• 186581-53-3 diazomethane 
• 92964-98-2 6-benzyloxy-benzofuran-2-carboxylic acid 

Downstream Products

• 244024-64-4 6-(6-(benzyloxy)benzofuran-2-yl)-3,5-dimethyl-4-hydroxy-2H-pyran-2-one 
• 568594-14-9 (6-(benzyloxy)benzofuran-2-yl)methanol 
• 13196-11-7 6-hydroxybenzofuran 

Relevant academic research and scientific papers

anti-oxidant composition comprising resveratrol analogues

The present invention provides an antioxidant composition containing a compound represented by chemical formula 1 as an antioxidant active component. In the chemical formula 1, X is O, S, or Se, and each R is independently selected from among hydrogen, an alkyl group having 1 to 12 carbon atoms, and an arylalkyl group having 7 to 15 carbon atoms. The present invention exhibits an excellent antioxidative effect, thereby being useful as the antioxidant composition.COPYRIGHT KIPO 2019

INHIBITORS OF HISTONE DEACETYLASE

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Benzofurylpyrone derivatives

There is provided benzofuryl-α-pyrone derivative represented by the following structural formula (I): wherein R1represents a hydrogen atom or an alkyl group of 1 to 5 carbons; R2represents hydrogen, —CO—R5or —SO2/sub